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2Abstract
Several studies have observed an increased risk of respiratory infections in subjects doing
heavy physical exercise. Vitamin C has been shown to affect some parts of the immune system,
and accordingly it seems biologically conceivable that it could have effects on the increased
incidence of respiratory infections caused by heavy physical stress. In this report the results of
three placebo-controlled studies that have examined the effect of vitamin C supplementation on
common cold incidence in subjects under acute physical stress are analyzed. In one study the
subjects were school-children at a skiing camp in the Swiss Alps, in another they were military
troops training in Northern Canada, and in the third they were participants in a 90 km running
race. In each of the three studies a considerable reduction in common cold incidence in the
group supplemented with vitamin C (0.6–1.0 g/day) was found. The pooled rate ratio (RR)
of common cold infections in the studies was 0.50 (95 % CI: 0.35–0.69) in favour of vitamin C
groups. Accordingly, the results of the three studies suggest that vitamin C supplementation
may be beneficial for some of the subjects doing heavy exercise who have problems with
frequent upper respiratory infections.
Introduction
Several studies have suggested that there is an increased risk of respiratory infections in
subjects doing heavy exercise (9,12,17,21,25,30). It is not well known what the physiological
basis of this increased susceptibility is (9,17), but decrease in the proliferative responses of
T-lymphocytes (8,9,13,17), depression of the immune system by corticosteroids produced
under physical stress (9,17), or harm done to the immune system cells by oxygen radicals
generated during heavy exercise (41) are among the possible explanations.
 Vitamin C has been reported to increase the proliferative responses in T-lymphocytes
(2,18,23,26,38), to prevent the defects in neutrophils caused by corticosteroids (5,27,36),
and it is also a major biological antioxidant (15). Thus vitamin C possibly could aid the
immune system in subjects under heavy physical stress. It is also noteworthy that the highest
concentrations of vitamin C in the body are found in the adrenal glands and adrenal vitamin C
is rapidly depleted by various forms of stress (20); however, the role of vitamin C in the
adrenal glands is not well understood. Moreover, in several laboratory animals vitamin C has
increased resistance to low temperature (6,39), further suggesting some role for the vitamin in
stress responses.
 Placebo-controlled studies have shown that vitamin C (? 1 g/day) decreases the severity of
common cold episodes (15,16). In contrast, vitamin C has not consistently affected the
common cold incidence, although a few studies have reported a significant decrease (15,16,28).
The largest studies have not found any marked effect on the incidence of colds (3,15,16,22,32).
Nevertheless, it is possible that vitamin C affects common cold incidence in certain limited
groups of people. The purpose of the present work was to assess the evidence from intervention
studies as to whether vitamin C supplementation affects the incidence of the common cold in
subjects under heavy physical stress.
Methods
Selection of studies
The literature on vitamin C-common cold studies has been thoroughly surveyed earlier (16,19), and an exhaustive
list of studies published prior to 1989 has been published (19). The previous searches were supplemented by
MEDLINE and SCISEARCH searches to identify vitamin C-common cold intervention studies published since
1988. For the present work, studies were selected in which the subjects were under heavy physical stress, and four
3randomized placebo-controlled double-blind studies were identified (refs. 31,32,34,37; Table 1). One study falling
within the selection criterion did not employ placebo tablets (4). No further vitamin C-common cold studies done
with subjects under comparable heavy physical stress were located. The remaining studies have typically been
carried out with subjects not exposed to considerable physical stress (15,16), e.g. adults at regular work (3) or
children at school (22).
Statistical methods
In Table 1 the proportion of subjects catching a common cold infection during the study (p) was calculated from
the published results (pC for the vitamin C group and pP for the placebo group). The 95 % confidence interval
(95 % CI) for the rate ratio (RR = pC/pP) found in each study was calculated with the normal distribution
approximation of the binomial distribution (1).
 In Table 1 the pooled RR and the 95 % CI were derived by averaging the individual logarithm values ln(RR)
using the inverses of variances var(ln(RR)) as the weights, with the formulae (1):
ln(RRpool) = ?ln(RRi) ? var(ln(RRi)) ? ?1 ? var(ln(RRi))
var(ln(RRpool)) = 1 ? ?1 ? var(ln(RRi))
95 % CI limits: RRUp,Low = RRpool × exp{±1.96?var(ln(RRpool))}
The p-value corresponding to the pooled estimate (Table 1) was derived from the standard normal deviate:
z = ln(RRpool) ? ? var(ln(RRpool)).
Dichotomous data were analyzed with Fisher's exact test. The 1-tailed p-value was calculated since the question
being considered in the present analysis is whether vitamin C decreases the incidence or not; there is no theoretical
or experimental reason to assume that higher vitamin C intake would increase the incidence of the common cold or
pneumonia.
Results
So far three randomized placebo-controlled double-blind studies have been carried out to test
whether vitamin C has an effect on the incidence (i.e. the occurrence of new cases over time) of
common cold infections in subjects under acute heavy physical stress (Table 1). Each of these
studies lasted for a few weeks only and there was at most one episode per subject. Ritzel
(28,34,35) conducted his study with school-children in a skiing camp in the Swiss Alps.
Sabiston and Radomski (37) did theirs with troops on a military exercise during the winter in
Northern Canada. Thus both of these studies used subjects under acute physical stress in a cold
environment. The study by Peters et al. (31) was carried out with subjects participating in a
long-distance running race (90 km) in South Africa. The subjects in this third study were thus
also under acute heavy physical stress, although they were not enduring a cold environment.
 Each of these three studies with subjects under acute heavy stress found a considerable
decrease in common cold incidence with vitamin C supplementation (Table 1). Furthermore,
the three studies form a fairly homogeneous group as regards the type of stress, and their results
may consequently be pooled together. Doing so yields a combined RR of 0.50 for common
cold infections in the vitamin C groups (Table 1). The probability that the differences between
the vitamin C and placebo groups are caused purely by chance is very small (p = 0.00003).
 The three studies in Table 1 were all placebo-controlled, but there is a further study
with subjects under acute physical stress but without using placebo tablets (4). Bessel-
Lorck (4) carried out a study with school-children in a skiing camp in the Bavarian woods,
and administered 1 g/day of vitamin C during a nine day period to the study group. There
were 9 cases of common cold among 20 control subjects but only 1 case among 26 subjects
4given vitamin C. It is unlikely that the difference in incidence in favour of the vitamin C
group is caused purely by chance (RR = 0.09, p = 0.001). However, as the control group
was not administered placebo, there may have been biases between the study groups.
Nevertheless, the result of the study is consistent with the placebo-controlled studies of
Table 1. The results from all four studies with subjects under acute heavy physical stress
identified in the literature have thus reported a decrease in common cold incidence in the
group supplemented with vitamin C (4,31,34,37).
Table 1. The effect of vitamin C on the common cold incidence in subjects
under acute heavy physical stress.
________________________________________________________________________________________________________
Study (ref.) Vitamin C group Placebo group RR 95% CI
Vit C Duration _______________________ _______________________
dose of study No.of No. Proportion No.of No. Proportion
(g/d) (weeks) subjects infected sick (pC) subjects infected sick (pP) (pC/pP)
Ritzel 1961 (28,34,35) 1 1 139 17 0.12 140 31 0.22 0.55 0.32-0.95
Sabiston, Radomski 1974 (37) 1 2 56 6 0.11 56 14 0.25 0.43 0.18-1.04
Peters et al. 1993 (31) 0.6 2 43 14 0.33 41 28 0.68 0.48 0.30-0.77
________
RRpool: 0.50 0.35-0.69
p = 0.00003
________________________________________________________________________________________________________
 One study was identified in which the experimental conditions are quite close to those
in the studies in Table 1. Pitt and Costrini carried out a randomized double-blind study with
military recruits in a training camp in South Carolina (32). They administered 2 g/day of
vitamin C to the study group, but there was no difference (0 %) in common cold incidence
when compared to the placebo group. There were over 1200 common cold episodes in the
study (32), i.e. over ten times the total number of episodes in the three studies in Table 1,
and thus this study has great weight as regards the possible role of vitamin C in subjects
under heavy stress. Nevertheless, there are several noteworthy differences between the Pitt
and Costrini study and the three studies of Table 1. Pitt and Costrini's subjects were under
a regular training program, the study lasted for 2 months and, furthermore, the tablet
administration did not begin until their third week at the training camp (32). In contrast, the
subjects of the studies in Table 1 were under acute and unusual stress and the studies lasted
for just few weeks. The body may adapt more efficiently to regular stress than to acute stress
and accordingly experimental differences may well explain the difference in results between
the studies of Table 1 and the Pitt and Costrini study. Moreover, the subjects of the Sabiston
and Radomski study, which is closest to the Pitt and Costrini study, were training in a cold
climate during the special arctic exercise, and were thus under much heavier stress.
Nevertheless, even though Pitt and Costrini found no decrease in common cold incidence,
they found a considerable decrease in the incidence of pneumonia in the vitamin C group
(32). There were 7 cases of pneumonia among the placebo subjects, but only 1 case among
the subjects receiving vitamin C (p = 0.04), suggesting that vitamin C supplementation
possibly did have some effects on susceptibility to infections in the Pitt and Costrini study.
5Discussion
In early 1970's Pauling concluded from previously published studies that vitamin C
supplementation decreases the incidence of the common cold (28). However, the majority
of studies carried out thereafter have not found that regular vitamin C supplementation
?? 1 g/day) has any marked effect on common cold incidence, indicating that the vitamin
has no particular preventive effect against colds in the general population of Western
countries (3,15,16,22). Nevertheless, a few studies have reported a significant decrease in
cold incidence with vitamin C supplementation. When a large number of studies are
carried out it is probable that some studies find great benefit purely by chance, and
therefore individual studies deviating from the great majority must be evaluated cautiously.
On the other hand, it is also possible that vitamin C has some real effect on susceptibility to
colds, but that the effects are quantitatively important only in limited groups of the general
population, and this was the basic assumption in the present work.
 Heavy physical stress was used as the criterion to select studies for the present analysis.
Three placebo-controlled studies with subjects under acute heavy physical stress were
identified, each of these studies having found a considerable decrease in common cold
incidence in the vitamin C group (Table 1). A comparable result was obtained in a fourth
study which did not employ placebo (4). However, a study by Pitt and Costrini with military
recruits found no decrease in common cold incidence with vitamin C supplementation,
although their subjects were under considerable stress during the study (32). The
experimental conditions in the latter study differ significantly from the conditions in the
three studies in Table 1, which may explain the conflicting results.
 The amount of stress from physical exercise does not divide people into two well-defined
groups, the variable having a continuous distribution instead. Also, the effect of
supplementation apparently depends on the initial dietary vitamin C intake. We may
accordingly conclude that the estimated 50 % decrease in the common cold incidence (Table 1)
is a crude estimate of the maximal benefit for subjects under acute heavy stress, and that there
is evidently a gradual decrease in the benefit from supplemental vitamin C both as the amount
of stress decreases and as the dietary vitamin C intake increases.
 Even though the studies in Table 1 indicate that vitamin C intake is associated with the
incidence of the common cold, the actual interpretation of the results is not obvious, for
example due to the lack of any knowledge on the dose-response relationship. The observed
difference in the study groups may be caused by a rather low vitamin C intake in the control
group ("marginal deficiency"), or by the high dose in the vitamin group. In the former case a
much smaller dose of supplement might produce a similar benefit, whereas in the latter case
the dose probably must be of the magnitude used in the studies (0.6–1.0 g/day) to obtain the
maximal benefit. Sabiston and Radomski (37) estimated that the food rations contained
approximately 40 mg/day of vitamin C, which is lower than the recommendation in the USA
(60 mg/day; ref. 24), but higher than in the UK (30 mg/day; ref. 40). They found that the
whole-blood vitamin C level was increased 100–150 % by vitamin C (1 g/day)
supplementation (37). Pitt and Costrini (32) found a much lower increase (50 %) with a
larger vitamin C dose (2 g/day). In healthy people plasma vitamin C level is saturated with
doses much below 1 g/day (10). Thus the vitamin C levels were apparently much lower in
the control group of Sabiston and Radomski than that of Pitt and Costrini, and this
represents a further noteworthy difference between the two studies. Ritzel did not estimate
the dietary intake of his subjects (34), but it seems probable that the intake was rather low at
the skiing camp in the Swiss Alps. Thus, in the studies by Ritzel and by Sabiston and
Radomski it cannot be determined whether the benefit from supplementation was due to "the
6correction of marginal deficiency" or the high supplementary doses. Peters et al. (32)
evaluated the dietary vitamin C intake and found it was on average 0.5 g/day in their
subjects, i.e. close to 10 times the RDA recommendation (60 mg/day; ref. 24). It seems then
that in Peters' study the effect was not caused by the correction of marginal deficiency, but
rather by the high dose of supplemental vitamin C per se (0.6 g/day).
 The suggestion that vitamin C may decrease common cold incidence particularly in
subjects under acute heavy stress is not a novel one. Peters et al. (31) were explicitly
interested in whether vitamin C supplementation is beneficial for long-distance runners and,
in fact, they did a parallel study with subjects not participating in the race which showed that
vitamin C did not decrease common cold incidence in the latter group (31). The present
analysis indicates that Peters' result with the long distance runners was not just a statistical
artifact among the large number of studies that have been carried out so far, as three other
studies with quite similar experimental conditions have also found a comparable decrease in
common cold incidence from vitamin C supplementation (4,34,37).
 Large-scale studies have shown that vitamin C supplements (? 1 g/day) do not prevent
common cold infections in ordinary people (3,15,16,22). Nevertheless, if vitamin C intake
has effects on common cold incidence even in limited groups of people it may be of
practical interest as the common cold is a frequent complaint. Furthermore, the issue is also
important more generally as regards nutritional recommendations. The goal of nutritional
recommendations is to prevent overt scurvy and for that purpose the recommendation
of 30–60 mg/day provides a good margin of safety. However, these recommendations are
not based either on clinical or epidemiological studies suggesting that 30 or 60 mg/day is an
optimal dose for human beings in the long term, or on biochemical studies suggesting that
such doses would saturate the numerous vitamin C dependent reactions (7,11,14,15,20,24,
29, 33). The studies analyzed in this paper suggest that there may be groups of people who
benefit from doses larger than those officially recommended.
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